Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Nevirapine (Viramune): European Warning

May 5, 2000

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

On April 12 the European Agency for the Evaluation of Medicinal Products (EMEA) issued a warning on risks of severe or life-threatening skin or liver reactions to nevirapine, requiring precautions especially for patients starting the drug, during their first 8 weeks of treatment. The full public statement is available at: http://www.eudra.org/humandocs/PDFs/PS/1126000EN.pdf

In the U.S., some but not all of this information is already in the drug labeling, and new data from clinical trials is being analyzed to fine-tune any additional warnings required.



ISSN # 1052-4207

Advertisement
Copyright 2000 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.


Back to the AIDS Treatment News May 5, 2000 contents page.

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News.
 
See Also
More on HIV Medications
More News on Nevirapine (Viramune)

Tools
 

Advertisement